MiR-26b modulates insulin sensitivity in adipocytes by interrupting the PTEN/PI3K/AKT pathway

International Journal of Obesity

Volumn 39, Issue 10, 2015, Pages 1523-1530

  Xu, G ^a   Ji, C ^b   Song, G ^b   Zhao, C ^a   Shi, C ^b   Song, L ^a   Chen, L ^b   Yang, L ^b   Huang, F ^b   Pang, L ^b   Zhang, N ^a   Zhao, Y ^a   Guo, X ^b  

^a The 82nd Hospital of the People's Liberation Army   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 4; INSULIN; MICRORNA; MICRORNA 26B; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; MIRN26 MICRORNA, RAT; PTEN PROTEIN, HUMAN; PTEN PROTEIN, RAT;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOINFORMATICS; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE OVEREXPRESSION; GENE TRANSLOCATION; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LUCIFERASE ASSAY; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; DISEASE MODEL; GENE EXPRESSION PROFILING; METABOLISM; MICROARRAY ANALYSIS; SPRAGUE DAWLEY RAT;

ADIPOCYTES; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; MAP KINASE SIGNALING SYSTEM; MICROARRAY ANALYSIS; MICRORNAS; OBESITY; PTEN PHOSPHOHYDROLASE; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84943450164     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2015.95     Document Type: Article

References (48)

1. World Health Organization. Office of Helath Communications and Public Relations. Obesity and Overweight. World Health Organization: Geneva, Switzerland, 2006.
2. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 2008; 32: 1431-1437.
3. Gupta N, Goel K, Shah P, Misra A. Childhood obesity in developing countries: epidemiology, determinants, and prevention. Endocr Rev. 2012; 33: 48-70.
4. Wu N, Tang X, Wu Y, Qin X, He L, Wang J, et al. Cohort profile: the Fangshan Cohort Study of cardiovascular epidemiology in Beijing, China. J Epidemiol. 2014; 24: 84-93.
5. Kasper NM, Herran OF, Villamor E. Obesity prevalence in Colombian adults is increasing fastest in lower socio-economic status groups and urban residents: results from two nationally representative surveys. Public Health Nutr. 2014; 17: 2398-2406.
6. Rottiers V, Naar AM. MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol. 2012; 13: 239-250.
7. Hilton C, Neville MJ, Karpe F. MicroRNAs in adipose tissue: their role in adipogenesis and obesity. Int J Obes (Lond) 2013; 37: 325-332.
8. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, et al A pancreatic islet-specific microRNA regulates insulin secretion. Nature. 2004; 432: 226-230.
9. Jordan SD, Kruger M, Willmes DM, Redemann N, Wunderlich FT, Bronneke HS, et al. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol. 2011; 13: 434-446.
10. Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008; 9: 367-377.
11. Heneghan HM, Miller N, Kerin MJ. Role of microRNAs in obesity and the metabolic syndrome. Obes Rev. 2010; 11: 354-361.
12. Alexander R, Lodish H, Sun L. MicroRNAs in adipogenesis and as therapeutic targets for obesity. Expert Opin Ther Targets. 2011; 15: 623-636.
13. Kang M, Yan LM, Zhang WY, Li YM, Tang AZ, Ou HS. Role of microRNA-21 in regulating 3T3-L1 adipocyte differentiation and adiponectin expression. Mol Biol Rep. 2013; 40: 5027-5034.
14. Zaragosi LE, Wdziekonski B, Brigand KL, Villageois P, Mari B, Waldmann R, et al. Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis. Genome Biol. 2011; 12: R64.
15. Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, Ravichandran LV, et al. MicroRNA-143 regulates adipocyte differentiation. J Biol Chem. 2004; 279: 52361-52365.
16. Ahn J, Lee H, Jung CH, Jeon TI, Ha TY. MicroRNA-146b promotes adipogenesis by suppressing the SIRT1-FOXO1 cascade. EMBO Mol Med. 2013; 5: 1602-1612.
17. Kim SY, Kim AY, Lee HW, Son YH, Lee GY, Lee JW, et al. MiR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. Biochem Biophys Res Commun. 2010; 392: 323-328.
18. Chen H, Wang S, Chen L, Chen Y, Wu M, Zhang Y, et al. MicroRNA-344 inhibits 3T3-L1 cell differentiation via targeting GSK3beta of Wnt/beta-catenin signaling pathway. FEBS Lett. 2014; 588: 429-435.
19. Chen L, Cui J, Hou J, Long J, Li C, Liu L A novel negative regulator of adipogenesis: microRNA-363. Stem Cells. 2014; 32: 510-520.
20. Keller P, Gburcik V, Petrovic N, Gallagher IJ, Nedergaard J, Cannon B, et al. Gene-chip studies of adipogenesis-regulated microRNAs in mouse primary adipocytes and human obesity. BMC Endocr Disord. 2011; 11: 7.
21. Heneghan HM, Miller N, McAnena OJ, O'Brien T, Kerin MJ. Differential miRNA expression in omental adipose tissue and in the circulation of obese patients identifies novel metabolic biomarkers. J Clin Endocrinol Metab. 2011; 96: E846-E850.
22. Balasubramanyam M, Aravind S, Gokulakrishnan K, Prabu P, Sathishkumar C, Ranjani H, et al. Impaired miR-146a expression links subclinical inflammation and insulin resistance in type 2 diabetes. Mol Cell Biochem. 2011; 351: 197-205.
23. Song G, Xu G, Ji C, Shi C, Shen Y, Chen L, et al. The role of microRNA-26b in human adipocyte differentiation and proliferation. Gene. 2014; 533: 481-487.
24. Nelson BA, Robinson KA, Buse MG. High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes. Diabetes. 2000; 49: 981-991.
25. Ceddia RB, Somwar R, Maida A, Fang X, Bikopoulos G, Sweeney G. Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetologia. 2005; 48: 132-139.
26. Palumbo T, Faucz FR, Azevedo M, Xekouki P, Iliopoulos D, Stratakis CA. Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTENAKT pathway. Oncogene. 2013; 32: 1651-1659.
27. Xie H, Lim B, Lodish HF. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes. 2009; 58: 1050-1057.
28. Xu G, Ji C, Shi C, Fu H, Zhu L, Xu L, et al. Modulation of hsa-miR-26b levels following adipokine stimulation. Mol Biol Rep. 2013; 40: 3577-3582.
29. Xu G, Shi C, Ji C, Song G, Chen L, Yang L, et al. Expression of microRNA-26b, an obesity-related microRNA, is regulated by free fatty acids, glucose, dexamethasone and growth hormone in human adipocytes. Mol Med Rep. 2014; 10: 223-228.
30. Trajkovski M, Hausser J, Soutschek J, Bhat B, Akin A, Zavolan M, et al. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature. 2011; 474: 649-653.
31. Kornfeld JW, Baitzel C, Konner AC, Nicholls HT, Vogt MC, Herrmanns K, et al. Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b. Nature. 2013; 494: 111-115.
32. Lebovitz HE, Banerji MA. Point: visceral adiposity is causally related to insulin resistance. Diabetes Care. 2005; 28: 2322-2325.
33. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007; 116: 39-48.
34. Verghese ET, Drury R, Green CA, Holliday DL, Lu X, Nash C, et al. Mir-26b is downregulated in carcinoma-Associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion. J Pathol. 2013; 231: 388-399.
35. Wu N, Zhao X, Liu M, Liu H, Yao W, Zhang Y, et al. Role of microRNA-26b in glioma development and its mediated regulation on Epha2. PloS one. 2011; 6: e16264.
36. Rahbari R, Holloway AK, He M, Khanafshar E, Clark OH, Kebebew E. Identification of differentially expressed microRNA in parathyroid tumors. Ann Surg Oncol. 2011; 18: 1158-1165.
37. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med. 2003; 348: 1625-1638.
38. Wolin KY, Carson K, Colditz GA. Obesity and cancer. Oncologist. 2010; 15: 556-565.
39. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol. 2006; 7: 85-96.
40. Tang X, Powelka AM, Soriano NA, Czech MP, Guilherme A. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes. J Biol Chem. 2005; 280: 22523-22529.
41. Kurlawalla-Martinez C, Stiles B, Wang Y, Devaskar SU, Kahn BB, Wu H. Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking Pten in adipose tissue. Mol Cell Biol. 2005; 25: 2498-2510.
42. Stiles B, Wang Y, Stahl A, Bassilian S, Lee WP, Kim YJ, et al. Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected]. Proc Natl Acad Sci USA. 2004; 101: 2082-2087.
43. Stiles BL, Kuralwalla-Martinez C, Guo W, Gregorian C, Wang Y, Tian J, et al. Selective deletion of Pten in pancreatic beta cells leads to increased islet mass and resistance to STZ-induced diabetes. Mol Cell Biol. 2006; 26: 2772-2781.
44. Wijesekara N, Konrad D, Eweida M, Jefferies C, Liadis N, Giacca A, et al. Muscle-specific Pten deletion protects against insulin resistance and diabetes. Mol Cell Biol. 2005; 25: 1135-1145.
45. Pal A, Barber TM, Van de Bunt M, Rudge SA, Zhang Q, Lachlan KL, et al. Pten mutations as a cause of constitutive insulin sensitivity and obesity. N Engl J Med. 2012; 367: 1002-1011.
46. Ishihara H, Sasaoka T, Kagawa S, Murakami S, Fukui K, Kawagishi Y, et al. Association of the polymorphisms in the 5'-untranslated region of Pten gene with type 2 diabetes in a Japanese population. FEBS Lett. 2003; 554: 450-454.
47. Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med. 2013; 368: 1685-1694.
48. Kasinski AL, Kelnar K, Stahlhut C, Orellana E, Zhao J, Shimer E, et al A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer. Oncogene. 2015; 34: 3547-3555.